Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 283.00K | -5.53M | -17.23M | 13.00M | -16.86M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 279.00K | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | -2.56M | 4.41M | 16.18M | -14.05M | 17.21M |
| Change in Net Operating Assets | -520.00K | 235.00K | 767.00K | 561.00K | -1.22M |
| Cash from Operations | -2.52M | -885.00K | -290.00K | -485.00K | -866.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2.50M | 896.00K | -- | -- | 740.00K |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 99.00K |
| Cash from Financing | 2.50M | 896.00K | -- | -- | 839.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.00K | 11.00K | -290.00K | -485.00K | -27.00K |